ABBOTT INDIA
|
The Current P/E Ratio of ABBOTT INDIA is 38.27.
| Share Price | ₹28,013.6 | Jul 17,2026 |
| Market Cap | ₹59,388.8 Cr | |
| Earnings-TTM | ₹1,552.0 Cr | TTM-Standalone Results |
| Price/Earnings | 38.27x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ABBOTT INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹59,388.8 Cr] as on Jul 17,2026
(/) Earnings [ ₹1,552.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 38.27x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay 38.27 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ABBOTT INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ABBOTT INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ABBOTT INDIA
PE Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 47.29x.
- ABBOTT INDIA 's operated at median p/e ratio of 47.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2023 at 49.43x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 46.11x.
How does ABBOTT INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ABBOTT INDIA | 1,552.02 | 38.27 | 59,388.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 40.11 | 463,815.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 75.03 | 192,678.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 75.46 | 161,323.0 |
| CIPLA LTD | 3,869.79 | 29.61 | 114,585.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 24.39 | 101,067.0 |
| MANKIND PHARMA LTD | 1,926.41 | 53.41 | 102,896.0 |
| LUPIN LTD | 5,355.47 | 20.85 | 111,661.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.68 | 113,990.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.21 | 88,265.9 |
| LAURUS LABS LTD | 889.85 | 92.87 | 82,639.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ABBOTT INDIA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.85x |
| Max industry PE | 92.87x |
| Median industry PE | 38.27x |
| Average industry PE | 45.26x |
You may also like the below Video Courses